Sihuan Pharmaceutical Holdings Group Ltd.

As of December 31, 2025, Sihuan Pharmaceutical Holdings Group Ltd. carries a market capitalization of 1.45B, placing it among publicly traded companies globally. Its enterprise value stands at 1.17B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Sihuan Pharmaceutical Holdings Group Ltd.'s next confirmed earnings release is scheduled for April 1, 2027.

As of December 31, 2025, Sihuan Pharmaceutical Holdings Group Ltd. has 9.04B shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Sihuan Pharmaceutical Holdings Group Ltd. maintains a current ratio of 1.80, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on July 14, 2026, Sihuan Pharmaceutical Holdings Group Ltd.'s stock has gained approximately 20.00% over the past 52 weeks.

As of December 31, 2025, Sihuan Pharmaceutical Holdings Group Ltd. holds 568.79M in cash and equivalents against 143.96M in total debt, resulting in a net debt position of -368.86M. Total book value stands at 836.52M, with working capital of 423.69M providing operational flexibility.

Sihuan Pharmaceutical Holdings Group Ltd.'s most recent stock split took place on June 5, 2014 with a 1:2 split ratio.